The researchers studied the impact of CCGs in the development of lower grade glioma and observed that certain genes including RORβ, NPAS2, and CRY1 were linked with elevated or reduced risk of lower grade glioma (Hou et al., 2024). Here, CRY1 is linked to central nervous system cancer.